{
    "nct_id": "NCT05027477",
    "official_title": "Customized Ablation of the Prostate With the TULSA Procedure Against Radical Prostatectomy Treatment: a Randomized Controlled Trial for Localized Prostate Cancer (CAPTAIN)",
    "inclusion_criteria": "* Male\n* Age 40 to 80 years, with >10 years life expectancy\n* NCCN (favorable and unfavourable) intermediate-risk prostate cancer on biopsy acquired within last 12 months\n* Stage ≤cT2c, N0, M0\n* ISUP Grade Group 2 or 3 disease on TRUS-guided biopsy or in-bore biopsy\n* PSA ≤20ng/mL within last 3 months\n* Treatment-naïve\n* Planned ablation volume is < 3 cm axial radius from urethra on mpMRI acquired within last 6 months\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 40 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "* Inability to undergo MRI or general anesthesia\n* Suspected tumor is > 30 mm from the prostatic urethra\n* Prostate calcifications > 3 mm in maximum extent obstructing ablation of tumor\n* Unresolved urinary tract infection or prostatitis\n* History of proctitis, bladder stones, hematuria, history of acute urinary retention, severe neurogenic bladder\n* Artificial urinary sphincter, penile implant, or intraprostatic implant\n* Patients who are otherwise not deemed candidates for radical prostatectomy\n* Inability or unwillingness to provide informed consent\n* History of anal or rectal fibrosis or stenosis, or urethral stenosis, or other abnormality challenging insertion of devices",
    "miscellaneous_criteria": ""
}